ICOCTI · Registering as Listener

International Conference on Oncology and Cancer Treatment Innovations

23rd Nov – 24th Nov 2026 Istanbul, Turkey Standard / Physical Participation
Listener Registration From
$—
$— in person
Registration Benefits:
Official invitation letterIssued automatically after registration
Certificate & digital materialsGet certificate, slides and resource materials
Supporting global researchConnect with researchers across 30+ countries

Select registration mode

Prices are shown before tax and bank charges — no surprises at checkout.

All sessions Networking Certificate Invitation letter Conference kit

Your details

We only need what's required to register and email your confirmation. Everything else is optional.

For Support Please Contact

Coupon code

Have a code? Apply it here — the discount updates the total immediately.

Apply
VISA MC AMEX UPI

Payments encrypted & processed securely. Refundable up to 14 days before the event.

Registration summary

ConferenceICOCTI
ModeStandard / Physical
ParticipationListener
Registration fee$—
Bank charges (5.8%)$—
Discount-$0.00
Total payable $—

Includes all bank processing charges — the amount above is exactly what will be charged. View charge breakdown

Need help?

Contact our registration team:

Benefits of Registering as Listener
Access to Conference Sessions
Networking Opportunities
Certificate of Participation
Invitation Letter Support
Conference Kit / Materials
Access to Keynote Sessions
Conference Session Tracks
SDG Wheel

SDG-Aligned Research Themes

International Conference on Oncology and Cancer Treatment Innovations conference tracks support global knowledge exchange, innovation, and sustainable development priorities across diverse disciplines.

SDG 3 - Good Health and Well-being SDG 4 - Quality Education SDG 9 - Industry, Innovation and Infrastructure SDG 10 - Reduced Inequalities

This track will explore the latest advancements in immunotherapy for cancer treatment, focusing on novel approaches and therapies. Discussions will include the mechanisms of action, clinical outcomes, and future directions in immunotherapeutic strategies.

This session will delve into the role of precision medicine in oncology, emphasizing personalized treatment plans based on genetic and molecular profiling. Participants will examine case studies and emerging technologies that enhance targeted therapies.

This track will highlight the importance of translational research in oncology, focusing on how laboratory discoveries can be effectively translated into clinical applications. Experts will discuss successful case studies and the challenges faced in this critical process.

This session will investigate the complexities of tumor biology and the tumor microenvironment, including cellular interactions and signaling pathways. Researchers will present findings on how these factors influence cancer progression and treatment responses.

This track will focus on innovative designs and methodologies in clinical trials for oncology treatments. Participants will discuss the implications of adaptive trial designs, patient recruitment strategies, and the integration of real-world evidence.

This session will cover the fundamental mechanisms underlying cancer biology, including genetic mutations and epigenetic modifications. Researchers will present novel therapeutic targets and their potential implications for treatment.

This track will address the intersection of health policy and oncology, focusing on the implications of policy decisions on cancer care delivery. Discussions will include access to treatments, healthcare disparities, and the impact of legislation on patient outcomes.

This session will explore cutting-edge technologies that are shaping the future of cancer treatment, including artificial intelligence and machine learning applications. Experts will discuss how these innovations can enhance diagnosis, treatment planning, and patient monitoring.

This track will focus on the unique challenges and innovative approaches in pediatric oncology. Participants will discuss recent advancements in treatment modalities and the importance of addressing the long-term effects of cancer therapies in children.

This session will examine strategies for cancer prevention and the importance of early detection in improving patient outcomes. Researchers will present findings on screening methods, risk assessment, and public health initiatives aimed at reducing cancer incidence.

This track will explore integrative approaches that combine conventional oncology treatments with complementary therapies. Discussions will focus on the evidence supporting these methods and their impact on patient quality of life and treatment efficacy.

COPYRIGHT © 2026 International Conference on Oncology and Cancer Treatment Innovations. ALL RIGHTS RESERVED